These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1803388)

  • 1. Effect of polyoxyethylene glycols (PEG) on properties of the matrix model of transdermal therapeutic system (TTS) with testosterone.
    Cichon R; Janicki S
    Pharmazie; 1991 Oct; 46(10):719-23. PubMed ID: 1803388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
    Realdon N; Ragazzi E; Ragazzi E
    Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products.
    Fruijtier-Pölloth C
    Toxicology; 2005 Oct; 214(1-2):1-38. PubMed ID: 16011869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic enhancement of testosterone transdermal delivery.
    Nicolazzo JA; Morgan TM; Reed BL; Finnin BC
    J Control Release; 2005 Apr; 103(3):577-85. PubMed ID: 15820405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of PEG chain length and density on amphiphilic macromolecular nanocarriers: self-assembled and unimolecular micelles.
    Wang J; del Rosario LS; Demirdirek B; Bae A; Uhrich KE
    Acta Biomater; 2009 Mar; 5(3):883-92. PubMed ID: 19038590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the aqueous dissolution of semicrystalline poly(ethylene oxide) using infrared chemical imaging: the effects of molecular weight and crystallinity.
    Coutts-Lendon C; Koenig JL
    Appl Spectrosc; 2005 Aug; 59(8):976-85. PubMed ID: 16105205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix modifications modulate ophthalmic drug delivery from photo-cross-linked poly(propylene fumarate)-based networks.
    Haesslein A; Hacker MC; Ueda H; Ammon DM; Borazjani RN; Kunzler JF; Salamone JC; Mikos AG
    J Biomater Sci Polym Ed; 2009; 20(1):49-69. PubMed ID: 19105900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential hydration and solubility of proteins in aqueous solutions of polyethylene glycol.
    Shulgin IL; Ruckenstein E
    Biophys Chem; 2006 Apr; 120(3):188-98. PubMed ID: 16377069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of the release of drugs from transdermal therapeutic systems. Presentation of a new release system].
    Chen LS; Ebel S; Hoffmann U; Osterwald HP
    Arzneimittelforschung; 1989 Nov; 39(11A):1494-7. PubMed ID: 2624596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyoxyethylene fatty acid esters as potential promotors of transdermal absorption for morphine hydrochloride and sulphate.
    Samczewska G; Piechota-Urbańska M; Kołodziejska J
    Polim Med; 2006; 36(2):17-32. PubMed ID: 17022153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of testosterone through rat skin from transdermal patch formulations.
    Satyanarayana S; Ganga S; Singh J
    Pharmazie; 1993 Jun; 48(6):467-8. PubMed ID: 8341733
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel mathematical model quantifying drug release from lipid implants.
    Siepmann F; Herrmann S; Winter G; Siepmann J
    J Control Release; 2008 Jun; 128(3):233-40. PubMed ID: 18442866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of furosemide from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Shin SC
    Int J Pharm; 2005 Aug; 299(1-2):127-33. PubMed ID: 15967605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of wettability and surface activity on release behavior of hydrophilic substances from lipid matrices.
    Koennings S; Berié A; Tessmar J; Blunk T; Goepferich A
    J Control Release; 2007 Jun; 119(2):173-81. PubMed ID: 17412444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of polyols on polyethylene glycol (PEG)-induced precipitation of proteins: Impact on solubility, stability and conformation.
    Kumar V; Sharma VK; Kalonia DS
    Int J Pharm; 2009 Jan; 366(1-2):38-43. PubMed ID: 18809481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of release rate and barrier transport of Diclofenac incorporated in hydrophilic matrices: role of cyclodextrins and implications in oral drug delivery.
    Miro A; Rondinone A; Nappi A; Ungaro F; Quaglia F; La Rotonda MI
    Eur J Pharm Biopharm; 2009 May; 72(1):76-82. PubMed ID: 19135532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water soluble drug delivery systems based on a non-biological bioadhesive polymeric system.
    Cappello B; Del Nobile MA; La Rotonda MI; Mensitieri G; Miro A; Nicolais L
    Farmaco; 1994 Dec; 49(12):809-18. PubMed ID: 7893338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of structural variations on drug release from lipid/polyethylene glycol matrices.
    Windbergs M; Strachan CJ; Kleinebudde P
    Eur J Pharm Sci; 2009 Jul; 37(5):555-62. PubMed ID: 19406229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Episodic transdermal delivery of testosterone.
    Malik R; Venkatesh KS; Dwivedi AK; Misra A
    Mol Pharm; 2012 Jun; 9(6):1537-43. PubMed ID: 22533605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.